Artificial Neural Networks to Optimize Formulation Components of a Fixed-Dose Combination of Rifampicin, Isoniazid and Pyrazinamide in a Microemulsion

B.D. Glass, S. Agatonovic-Kustrin, M.H. Wisch

Research output: Contribution to journalArticle

11 Citations (Scopus)
Original languageEnglish
Pages (from-to)195-201
JournalCurrent Drug Discovery Technologies
Volume2
DOIs
Publication statusPublished - 2005

Cite this